We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.28%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.53B
AUM Growth
-$382M
Cap. Flow
+$195M
Cap. Flow %
2.99%
Top 10 Hldgs %
59.37%
Holding
305
New
83
Increased
54
Reduced
76
Closed
50

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$108M
2
BUD icon
AB InBev
BUD
+$39.8M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$33.9M
4
CRL icon
Charles River Laboratories
CRL
+$32M
5
CL icon
Colgate-Palmolive
CL
+$27M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$93.3M
2
PFE icon
Pfizer
PFE
+$76.9M
3
JNJ icon
Johnson & Johnson
JNJ
+$53.7M
4
INCY icon
Incyte
INCY
+$46.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.38%
2 Consumer Staples 6.6%
3 Technology 4.23%
4 Consumer Discretionary 3.89%
5 Communication Services 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONFOW icon
226
Onfolio Holdings Warrant
ONFOW
$64.5K
$53.4K ﹤0.01%
400,000
– –
NLSPW
227
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$52.6K ﹤0.01%
500,000
– –
LCFYW icon
228
Locafy Ltd Warrant
LCFYW
$47.3K ﹤0.01%
12,121
– –
ACONW icon
229
Aclarion Warrant
ACONW
$49.4K
$41.3K ﹤0.01%
550,000
– –
MOBBW
230
Mobilicom Ltd Warrants
MOBBW
$2.83B
$38.7K ﹤0.01%
242,100
– –
SVREW
231
SaverOne 2014 Ltd Warrant
SVREW
$36.3K ﹤0.01%
242,100
– –
GROY.WS
232
DELISTED
Gold Royalty Corp. Warrants, each warrant exercisable for one common share at an exercise price of $7.50
GROY.WS
$33.6K ﹤0.01%
448,000
– –
IVDAW icon
233
Iveda Solutions Warrant
IVDAW
$47.8K
$31.8K ﹤0.01%
145,000
– –
SNES icon
234
SenesTech
SNES
$7M
$29.6K ﹤0.01%
+587
New +$52.7K
DFSCW
235
DEFSEC Technologies Warrant
DFSCW
$28.7K ﹤0.01%
120,000
– –
RVSNW icon
236
Rail Vision Ltd Warrant
RVSNW
$725K
$27.2K ﹤0.01%
1,089,500
– –
FREEW
237
DELISTED
Whole Earth Brands, Inc. Warrant
FREEW
$25.4K ﹤0.01%
211,300
– –
SWAGW icon
238
Stran & Company Warrant
SWAGW
$66.4K
$24.5K ﹤0.01%
545,000
– –
NEXRW
239
Nexera Technologies Ltd Warrant
NEXRW
$48.9K
$21.4K ﹤0.01%
480,769
– –
BIAFW icon
240
bioAffinity Technologies
BIAFW
$18.6K ﹤0.01%
204,082
– –
HSCSW icon
241
HeartSciences Inc Warrant
HSCSW
$71K
$17.6K ﹤0.01%
352,941
– –
BSFC
242
DELISTED
Blue Star Foods Corp. Common Stock
BSFC
$14.3K ﹤0.01%
+1,100
New +$42.2K
BNCWW
243
CEA Industries Inc Warrant
BNCWW
$14K ﹤0.01%
700,000
– –
AGRIW
244
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$11.9K ﹤0.01%
600,000
– –
AIMDW icon
245
Ainos Warrants
AIMDW
$80.7K
$8.18K ﹤0.01%
25,000
– –
NXLIW
246
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$8.13K ﹤0.01%
325,000
– –
TNONW icon
247
Tenon Medical Inc Warrant
TNONW
$1.49K
$7.26K ﹤0.01%
178,000
-1,602,000
-90% -$118K
KTTAW icon
248
Pasithea Therapeutics Warrants
KTTAW
$5.69K
$6.2K ﹤0.01%
1,000,000
– –
BRSHW
249
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$839 ﹤0.01%
24,038
-576,924
-96% -$21.9K
TCBPW
250
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$787 ﹤0.01%
37,647
– –
8 9
10
11 12

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Armistice Capital held 305 positions worth $6.53B, down 5.5% from $6.91B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Armistice Capital's Q3 2023 filing shows 83 new, 54 increased, 76 reduced and 50 closed positions. Its largest new stake was AB InBev: 703,000 shares worth $38.9M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $93.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 39% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q3 2023 buy was AB InBev: 703,000 shares worth $38.9M.
  • Armistice Capital added most to PTC Therapeutics in Q3 2023, an estimated $108M increase.
  • Armistice Capital's biggest Q3 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $93.3M.
  • Armistice Capital fully exited Pfizer in Q3 2023, selling an estimated $76.9M.
  • Armistice Capital's ten largest holdings make up 59% of its $6.53B portfolio in Q3 2023.
  • Armistice Capital opened 83 new positions and closed 50 in Q3 2023.
  • Armistice Capital's portfolio value fell 5.5% quarter-over-quarter to $6.53B.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.